UNSPSC 51352308: Pipendoxifene

This classification denotes a selective estrogen receptor modulator with the molecular formula C29H32N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TPC5Q8496G. The term PIPENDOXIFENE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 15 no. 3-4, 2001, list 46. ). Most nations schedule pipendoxifene under HS 29333999 and SITC 51574. As of Q4 2014, PIPENDOXIFENE remains the US FDA Preferred Term for this commodity.

Pipendoxifene bears US NLM identifiers UMLS ID C0935699 and NCI Concept Code C1874. SMILES: CC1=C(N(C2=C1C=C(C=C2)O)CC3=CC=C(C=C3)OCCN4CCCCC4)C5=CC=C(C=C5)O.

UNSPSC 51352308 Pipendoxifene, a Commodity code, identifies a specialized pharmaceutical ingredient with minimal recent state and local procurement activity. The source provides no records of recent opportunities solicited under this code by state agencies, counties, cities, school districts, transit authorities, or other state and local public bodies. Pipendoxifene is a selective estrogen receptor modulator used in pharmaceutical manufacturing; state and local governments do not typically procure this ingredient directly, as it falls within the supply chain of pharmaceutical manufacturers and distributors rather than end-use procurement by public entities. The code's narrow scope and pharmaceutical-manufacturing focus place it outside the mainstream of state and local government contracting.

Without documented recent solicitations in the available data, no geographic concentration or issuing-body pattern can be identified. This code warrants a skip unless your firm operates within pharmaceutical supply-chain services to state-contracted healthcare or research institutions, in which case monitoring for specialized research or clinical-trial procurement would be warranted.